Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda ; volume:24 ; number:1 ; day:28 ; month:8 ; year:2024 ; pages:1-14 ; date:12.2024
BMC infectious diseases ; 24, Heft 1 (28.8.2024), 1-14, 12.2024
- Creator
-
Zakumumpa, Henry
Alinaitwe, Adolf
Kyomuhendo, Marjorie
Nakazibwe, Brenda
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-024-09748-5
- URN
-
urn:nbn:de:101:1-2411132123196.329141477706
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zakumumpa, Henry
- Alinaitwe, Adolf
- Kyomuhendo, Marjorie
- Nakazibwe, Brenda
- SpringerLink (Online service)
Other Objects (12)
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study